Prostaglandin E2, Produced by Mast Cells in Colon Tissues From Patients With Irritable Bowel Syndrome, Contributes to Visceral Hypersensitivity in Mice
Open Access
- 19 February 2020
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 158 (8), 2195-2207.e6
- https://doi.org/10.1053/j.gastro.2020.02.022
Abstract
No abstract availableFunding Information
- National Institutes of Health
This publication has 38 references indexed in Scilit:
- Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndromeAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2012
- Diabetic Visceral Hypersensitivity Is Associated With Activation of Mitogen-Activated Kinase in Rat Dorsal Root GangliaDiabetes, 2011
- In vitro and in vivo characterization of PF‐04418948, a novel, potent and selective prostaglandin EP2 receptor antagonistBritish Journal of Pharmacology, 2011
- The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndromeGut, 2010
- Subdiaphragmatic vagal afferent nerves modulate visceral painAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Role for protease activity in visceral pain in irritable bowel syndromeJCI Insight, 2007
- Peripheral and Central Contributions to Hyperalgesia in Irritable Bowel SyndromeThe Journal of Pain, 2006
- Terminal ileal mucosal mast cells in irritable bowel syndromeDigestive Diseases and Sciences, 1993
- Recent advances in the cellular and molecular biology of mast cellsImmunology Today, 1989
- Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndromeGut, 1973